![Jamie Kasuboski](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Jamie Kasuboski
Oprichter bij
Avilar Therapeutics, Inc.
Profiel
Jamie is a Vice President with OMX Ventures.
Prior to OMX Jamie developed deep experience in early-stage Biotech investing and company creation while working on the investment team at RA Capital.
In that role he served on the board of Enara Bio, Avilar Therapeutics, and Endor Therapeutics.
Before joining RA, he was a Director at Boehringer Ingelheim Venture Fund and served as a Board Director of both Tilos Therapeutics (acquired by Merck & Co.) and Rewind Therapeutics.
Education: PhD in Molecular and Cellular Biology from the University of Notre Dame and a BS in Biology with a minor in Chemistry from Hillsdale College
Actieve functies van Jamie Kasuboski
| Bedrijven | Functie | Begin |
|---|---|---|
ReAx Biotechnologies
 ReAx Biotechnologies BiotechnologyHealth Technology Engages in drug discovery activities and development of molecular therapies | Directeur/Bestuurslid | 01-12-2021 |
Seeker Biologics, Inc.
 Seeker Biologics, Inc. BiotechnologyHealth Technology Develops immunological therapeutic drugs | Directeur/Bestuurslid | 01-09-2021 |
Glyphic Biotechnologies Inc
 Glyphic Biotechnologies Inc Miscellaneous Commercial ServicesCommercial Services Operates as a biotechnology company which develops protein sequencing platform to enable researchers to gain novel insights into biology and disease | Directeur/Bestuurslid | 01-04-2021 |
Chicago Biomedical Consortium | Consultant / Adviseur | 01-04-2022 |
Avilar Therapeutics, Inc.
 Avilar Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a biotechnology company which develops covalent drugs to treat cancer and other autoimmune diseases | Oprichter | 01-11-2019 |
LUMA Group
 LUMA Group Investment ManagersFinance LUMA Group is an active manager. | Private Equity Investor | - |
Eerdere bekende functies van Jamie Kasuboski
| Bedrijven | Functie | Einde |
|---|---|---|
Omx Ventures LLC
 Omx Ventures LLC Investment ManagersFinance OMX Ventures invests in companies located across the United States, United Kingdom and Europe. The firm targets companies operating in the fields of therapeutics, Synthetic biology, biotools and diagnostics sectors. It provides financing for seed and early-stage capital requirements and also makes follow- on investments. | Private Equity Investor | 01-02-2024 |
Enara Bio Ltd.
 Enara Bio Ltd. BiotechnologyHealth Technology Develops cancer therapies | Directeur/Bestuurslid | 01-02-2021 |
ReWind Therapeutics NV
 ReWind Therapeutics NV Pharmaceuticals: MajorHealth Technology Develops novel re-myelinating therapies | Directeur/Bestuurslid | 01-09-2019 |
| ░░░░░░░░░░ ░░░░░░░░░ ░░░░░░░ ░░░░ | ░░░░░░░ ░░░░░░ ░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░ ░░░░░░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ |
Opleiding van Jamie Kasuboski
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
95
Eerstegraads connecties
13
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 13 |
|---|---|
University of Notre Dame
 University of Notre Dame Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Hillsdale College
 Hillsdale College Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Boehringer Ingelheim Venture Fund
 Boehringer Ingelheim Venture Fund Investment ManagersFinance Acts as Family of Funds | Finance |
Tilos Therapeutics, Inc.
 Tilos Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops antibody therapeutics for cancer, fibrosis and autoimmune disease | Health Technology |
ReWind Therapeutics NV
ReWind Therapeutics NV Pharmaceuticals: MajorHealth Technology Develops novel re-myelinating therapies | Health Technology |
Chicago Biomedical Consortium | |
Omx Ventures LLC
Omx Ventures LLC Investment ManagersFinance OMX Ventures invests in companies located across the United States, United Kingdom and Europe. The firm targets companies operating in the fields of therapeutics, Synthetic biology, biotools and diagnostics sectors. It provides financing for seed and early-stage capital requirements and also makes follow- on investments. | Finance |
Avilar Therapeutics, Inc.
Avilar Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a biotechnology company which develops covalent drugs to treat cancer and other autoimmune diseases | Commercial Services |
LUMA Group
LUMA Group Investment ManagersFinance LUMA Group is an active manager. | Finance |
Glyphic Biotechnologies Inc
Glyphic Biotechnologies Inc Miscellaneous Commercial ServicesCommercial Services Operates as a biotechnology company which develops protein sequencing platform to enable researchers to gain novel insights into biology and disease | Commercial Services |
Enara Bio Ltd.
Enara Bio Ltd. BiotechnologyHealth Technology Develops cancer therapies | Health Technology |
ReAx Biotechnologies
ReAx Biotechnologies BiotechnologyHealth Technology Engages in drug discovery activities and development of molecular therapies | Health Technology |
Seeker Biologics, Inc.
Seeker Biologics, Inc. BiotechnologyHealth Technology Develops immunological therapeutic drugs | Health Technology |
